3D Printing Copper ink

Merck Life Science S.L

Revision date : 2025-08-29

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07 GHS08
Health risk rating 5
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

200-838-9/75-09-2

Name of the chemical

Methylene chloride

Concentration

>=10-<20

EC/CAS

203-905-0/111-76-2

Name of the chemical

Ethylene glycol monobutyl ether (EGBE)

Concentration

>=1-<10

General Information

Version

9.1

Revision date

2025-08-29

Product name

3D Printing Copper ink

REACH No

This

1.2.2. Uses advised against

For R&D use only. Not for pharmaceutical, household or other uses

Emergency telephone

+(34)-931768545

Icons in SDS

GHS07 GHS08

Company Information

company name

Merck Life Science S.L

e-mail address of the competent person responsible for the Safety Data Sheet

serviciotecnico@merckgroup.com

GHS Information

Signal word

Danger

Hazard Codes

Hazard statements (CLP)

H315, H319, H351, H360D

Hazard statements

Code

Statements

H315

Causes skin irritation

Section 2

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture Skin irritation, (Category 2) H315: Causes skin irritation Eye irritation, (Category 2) H319: Causes serious eye irritation Carcinogenicity, (Category 2) H351: Suspected of causing cancer Reproductive toxicity, (Category H360D: May damage the unborn child 1B) Endocrine disruptor for human EUH380: May cause endocrine disruption in health, (Category 1) humans Endocrine disruptor for EUH430: May cause endocrine disruption in environment, (Category 1) the environment.

Signal word

Danger Danger

Hazard statements

H315 Causes skin irritation. H319 Causes serious eye irritation. H351 Suspected of causing cancer. H360D May damage the unborn child. EUH380 May cause endocrine disruption in humans. EUH430 May cause endocrine disruption in the environment. Restricted to professional users. Reduced Labelling (<= 125 ml) H351 Suspected of causing cancer. EUH380 May cause endocrine disruption in humans. EUH430 May cause endocrine disruption in the environment. H360D May damage the unborn child.

Precautionary statements

P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P263 Avoid contact during pregnancy and while nursing. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P391 Collect spillage. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant. P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P263 Avoid contact during pregnancy and while nursing. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P391 Collect spillage. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant.

Supplemental label elements

none none

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

ECOLOGICAL INFORMATION

This substance/mixture contains components considered to have endocrine disrupting properties for environment , according to REACH Article 57(f), Commission Regulation (EU) 2018/605 or Commission Delegated Regulation (EU) 2017/2100.

TOXICOLOGICAL INFORMATION

This substance/mixture contains components considered to have endocrine disrupting properties affecting human health, according to REACH Article 57(f), Commission Regulation (EU) 2018/605 or Commission Delegated Regulation (EU) 2017/2100.

2.1 Classification of the substance or mixture

Skin irritation, (Category 2) H315: Causes skin irritation. Eye irritation, (Category 2) H319: Causes serious eye irritation. Carcinogenicity, (Category 2) H351: Suspected of causing cancer. Reproductive toxicity, (Category H360D: May damage the unborn child. 1B) Endocrine disruptor for human EUH380: May cause endocrine disruption in health, (Category 1) humans. Endocrine disruptor for EUH430: May cause endocrine disruption in environment, (Category 1) the environment.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.